Comparison of ion channel inhibitor combinations for limiting secondary degeneration following partial optic nerve

Lillian M Toomey1, Carole A Bartlett1, Maimuna Majimbi2

  • 1Experimental and Regenerative Neurosciences, School of Biological Sciences, The University of Western Australia, 35 Stirling Hwy, Perth, WA, 6009, Australia.

Insights

A new drug combination, lomerizine plus Brilliant Blue G (BBG) and YM872, effectively limits secondary degeneration after optic nerve injury. This treatment preserves nerve structure and visual function, offering a promising alternative for neurotrauma recovery.

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Pharmacology

Background:

  • Secondary degeneration following neurotrauma exacerbates neuronal and glial loss, leading to functional deficits.
  • Previous studies indicated that a combination of ion channel inhibitors (lomerizine + oxATP + YM872) could mitigate secondary degeneration.
  • Brilliant Blue G (BBG) is a more clinically applicable P2X7 receptor inhibitor than oxATP.

Purpose of the Study:

  • To evaluate the efficacy of a novel ion channel inhibitor combination (lomerizine + BBG + YM872) in limiting secondary degeneration after optic nerve injury.
  • To compare the effectiveness of BBG-containing combination with the oxATP-containing combination in a rat model.

Main Methods:

  • Partial optic nerve transection was performed in adult female rats to induce secondary degeneration.
  • Animals received local treatment via osmotic mini-pump with either lomerizine + oxATP + YM872 or lomerizine + BBG + YM872.
  • Evaluated outcomes included microglial/macrophage counts (Iba1+, ED1+), oligodendroglial cell numbers, node/paranode structure, and visual function (optokinetic nystagmus test).

Main Results:

  • The lomerizine + BBG + YM872 combination demonstrated comparable efficacy to the lomerizine + oxATP + YM872 combination in preserving node/paranode structure and visual function.
  • Neither combination significantly improved microglial/macrophage or oligodendroglial cell counts compared to vehicle controls.
  • Local delivery of the BBG-based ion channel inhibitor combination effectively limited secondary degeneration.

Conclusions:

  • A locally delivered combination of lomerizine, BBG, and YM872 is as effective as the oxATP-containing combination in limiting secondary degeneration after partial optic nerve injury.
  • This BBG-based combination shows promise for preserving structural integrity and visual function in neurotrauma models.
  • Further research may be needed to enhance effects on glial cell populations.

Related Concept Videos

Ion Channels01:19

Ion Channels

The movement of ions like sodium, potassium, and calcium into and out of the cell is essential to maintain the electrochemical gradient in living cells. The ion channels—a class of membrane transport proteins—help maintain this ionic gradient for the smooth functioning of physiological activities such as maintaining cell size and volume, conducting nerve impulses, and gas and nutrient exchange.
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...
91.4K
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
8.2K
Mechanically-gated Ion Channels01:12

Mechanically-gated Ion Channels

Mechanically-gated ion channels are proteins found in eukaryotic and prokaryotic cell membranes that open in response to mechanical stress. Tension, compression, swelling, and shear stress can alter the conformation of the protein, opening a transmembrane channel that allows the passage of ions for signal transmission. In eukaryotes, mechanically-gated channels are distributed in several regions like the neurons, lungs, skin, bladder, and heart, where they play critical roles in numerous...
7.7K
Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
14.3K
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
10.8K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
5.7K